CD133-targeted afatinib nanomicelles for enhanced lung cancer theranostics.
Leng D, Cao K, Hao Q, Peng Z, Pan G, Liu J, Yu J, Tang J, Li J, Chen H, Chen H, Tang H.
Leng D, et al. Among authors: yu j.
Nanomedicine (Lond). 2024 Nov 27:1-13. doi: 10.1080/17435889.2024.2422804. Online ahead of print.
Nanomedicine (Lond). 2024.
PMID: 39601387